Macquarie Group
ASMB icon

Macquarie Group’s Assembly Biosciences ASMB Stock Holding History

Macquarie Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-76
Closed -$2K – 2621
2021
Q4 		$2K Hold
76
– – ﹤0.01% 2589
2021
Q3 		$3K Hold
76
– – ﹤0.01% 2608
2021
Q2 		$4K Hold
76
– – ﹤0.01% 2533
2021
Q1 		$4K Sell
76
-23
-23% -$1.52K ﹤0.01% 2451
2020
Q4 		$7K Hold
99
– – ﹤0.01% 2330
2020
Q3 		$20K Hold
99
– – ﹤0.01% 2162
2020
Q2 		$28K Buy
+99
New +$23.1K ﹤0.01% 2072

Other funds holding ASMB

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's ASMB Position: Q1 2022 in Review

Macquarie Group sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 76 shares — an estimated $2K sold.

Macquarie Group first reported a position in ASMB in Q2 2020 and held it in 7 quarters. The position peaked at $28K in Q2 2020. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

  • Macquarie Group reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
  • Macquarie Group sold 76 Assembly Biosciences shares in Q1 2022, an estimated $2K.
  • Macquarie Group first reported a position in Assembly Biosciences in Q2 2020 and held it in 7 quarters.
  • Macquarie Group's Assembly Biosciences position peaked at $28K in Q2 2020.
  • 54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on Macquarie Group's 13F filing for Q1 2022, filed 16 May 2022.